Loading...
Clinical analysis of bevacizumab targeting therapy in treating early colorectal carcinoma after operation
Clinical effects of bevacizumab target therapy in treating early colorectal carcinoma (CRC) after resection were analyzed. Ninety-two patients diagnosed with early CRC and treated with endoscopic mucosal resection for the first time were selected for the study. They were randomly divided into the co...
Na minha lista:
Udgivet i: | Oncol Lett |
---|---|
Main Authors: | , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
D.A. Spandidos
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5452938/ https://ncbi.nlm.nih.gov/pubmed/28599469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6087 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|